Using AI imaging to improve blood sugar control in diabetic patients
Official title: The Impact of AI-Based Fundus Imaging on Blood Glucose Control and Fundus Examination Completion Rates in Outpatient Diabetic Patients
Run by Sichuan Provincial People's Hospital · NCT06819423 · Data updated 2026-11-12
This study is testing whether using AI imaging can help people with diabetes better control their blood sugar and get more eye exams done.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Sichuan Provincial People's Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | December 26, 2024 |
| Main results expected | December 26, 2025 |
| Study ends | December 26, 2025 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT06819423 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with Type 2 Diabetes Mellitus and an HbA1c level greater than 7%.
✕Probably not a fit
Patients without a prior diabetic fundus examination or those with known diabetic retinopathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates how AI-based fundus imaging affects blood glucose control and the completion rates of eye examinations in diabetic patients. It involves a randomized controlled trial with 200 participants, divided into an intervention group receiving AI imaging and a control group receiving standard education. The primary outcomes measured will include blood glucose levels and the rates of completed fundus examinations. The study is conducted at Sichuan Provincial People's Hospital over a one-year period.
Why it matters
Potential benefit: If successful, this approach could enhance blood glucose management and increase the rate of necessary eye examinations for diabetic patients.
How similar studies have gone: Other studies have shown promising results with AI imaging in diabetic care, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Diagnosis of Type 2 Diabetes Mellitus. * Patients with a glycated hemoglobin (HbA1c) level \> 7%. * Ability to comply with all required examinations and provide signed informed consent. Exclusion Criteria: * No previous diabetic fundus examination. * No known diabetic retinopathy. * Absence of other ocular diseases that could lead to retinopathy. * Subjects from whom clear fundus photographs could not be obtained. * Patients with comorbid malignant tumors or severe cardiovascular diseases. * Patients anticipated to have difficulties with follow-up or those residing in other provinces.
Where it's running
-
Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Jie Li, doctor
- Email: lijieyk@med.uestc.edu.cn
- Phone: +86 139 0809 4675
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.